doi: 10.1016/0092-1157(77)90007-5.
Approaches to the validation of animal test systems for assay of protective potency of BCG vaccines
- PMID: 407231
- DOI: 10.1016/0092-1157(77)90007-5
Item in Clipboard
Approaches to the validation of animal test systems for assay of protective potency of BCG vaccines
J Biol Stand.
1977.
Abstract
Three animal test systems, two in guinea-pigs and one in mice, have been examined to differentiate the ability of three BCG vaccines with respect to their ability to protect the animals against infection when challenged with virulent bacilli. One test system showed great promise and was examined in greater detail in order to explain the mechanism of protection. These studies are continuing in order to test a series of BCG vaccines that will be given to groups of children and their protective effect observed.
Similar articles
-
Infection with Mycobacterium avium-intracellulare and the protective effects of Bacille Calmette-Guérin.J Infect Dis. 1982 May;145(5):733-41. doi: 10.1093/infdis/145.2.733. J Infect Dis. 1982. PMID: 6804577
-
Potency of 10 BCG vaccines as evaluated by their influence on the bacillemic phase of experimental airborne tuberculosis in guinea-pigs.J Biol Stand. 1979 Jul;7(3):179-97. doi: 10.1016/s0092-1157(79)80021-9. J Biol Stand. 1979. PMID: 387796 No abstract available.
-
[Novel vaccines against M. tuberculosis].Kekkaku. 2006 Dec;81(12):745-51. Kekkaku. 2006. PMID: 17240920 Review. Japanese.
-
Boosting with recombinant MVA expressing M. tuberculosis α-crystallin antigen augments the protection imparted by BCG against tuberculosis in guinea pigs.Sci Rep. 2017 Dec 11;7(1):17286. doi: 10.1038/s41598-017-17587-5. Sci Rep. 2017. PMID: 29230061 Free PMC article.
-
Evaluation of the protective potency of new tuberculosis vaccines.Rev Infect Dis. 1989 Mar-Apr;11 Suppl 2:S484-90. doi: 10.1093/clinids/11.supplement_2.s484. Rev Infect Dis. 1989. PMID: 2652259 Review.